What Investors Need to Know About Coronavirus Variants
The rollouts of the COVID-19 vaccines developed by Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) with its partner BioNTech (NASDAQ: BNTX) are well under way. However, there are now new variants of SARS-CoV-2 that are different than the one for which the vaccines were initially tested. In this Motley Fool Live video recorded on Jan. 13, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights discuss what investors need to know about these new coronavirus variants.
Source Fool.com